Neurorescue activity, APP regulation and amyloid-beta peptide reduction by novel multi-functional brain permeable iron- chelating- antioxidants, M-30 and green tea polyphenol, EGCG.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Current Alzheimer Research

• Publication date

  2007-08-31

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.2174/156720507781788927PMID 17908043
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Drug discovery targeted to the Alzheimer’s APP mRNA 5′-untranslated region

  2007cited by this paper
• Long-term administration of green tea catechins improves spatial cognition learning ability in rats.

  2006cited by this paper
• Multifunctional Activities of Green Tea Catechins in Neuroprotection

  2005cited by this paper
• Desferrioxamine and vitamin E protect against iron and MPTP-induced neurodegeneration in mice

  2005cited by this paper
• Regulation of Bcl‐2 family proteins, neurotrophic factors, and APP processing in the neurorescue activity of propargylamine

  2005cited by this paper
• Rasagiline: Neurodegeneration, neuroprotection, and mitochondrial permeability transition

  2005cited by this paper
• Rasagiline as an adjunct to levodopa in patients with Parkinson's disease and motor fluctuations (LARGO, Lasting effect in Adjunct therapy with Rasagiline Given Once daily, study): a randomised, double-blind, parallel-group trial.

  2005cited by this paper
• Green tea polyphenol (–)‐epigallocatechin‐3‐gallate induces neurorescue of long‐term serum‐deprived PC12 cells and promotes neurite outgrowth

  2005cited by this paper
• Novel multifunctional neuroprotective iron chelator‐monoamine oxidase inhibitor drugs for neurodegenerative diseases. In vivo selective brain monoamine oxidase inhibition and prevention of MPTP‐induced striatal dopamine depletion

  2005cited by this paper
• Design, synthesis, and evaluation of novel bifunctional iron-chelators as potential agents for neuroprotection in Alzheimer's, Parkinson's, and other neurodegenerative diseases.

  2005cited by this paper
• Bifunctional drug derivatives of MAO-B inhibitor rasagiline and iron chelator VK-28 as a more effective approach to treatment of brain ageing and ageing neurodegenerative diseases.

  2005cited by this paper
• Metals in our minds: therapeutic implications for neurodegenerative disorders.

  2004cited by this paper
• Iron, brain ageing and neurodegenerative disorders

  2004cited by this paper
• Neuronal Apoptosis: BH3-Only Proteins the Real Killers?

  2004cited by this paper
• N-Propargyl-1 (R)-aminoindan, rasagiline, increases glial cell line-derived neurotrophic factor (GDNF) in neuroblastoma SH-SY5Y cells through activation of NF-kappaB transcription factor.

  2004cited by this paper
• Neurodegenerative diseases and oxidative stress

  2004cited by this paper
• Neuroprotection via pro‐survival protein kinase C isoforms associated with Bcl‐2 family members

  2004cited by this paper
• Preliminary studies of a novel bifunctional metal chelator targeting Alzheimer's amyloidogenesis.

  2004cited by this paper
• Novel bifunctional drugs targeting monoamine oxidase inhibition and iron chelation as an approach to neuroprotection in Parkinson’s disease and other neurodegenerative diseases

  2004cited by this paper
• Neuroprotection by a novel brain permeable iron chelator, VK-28, against 6-hydroxydopamine lession in rats.

  2004cited by this paper
• The importance of propargylamine moiety in the anti‐ Parkinson drug rasagiline and its derivatives for MAPK‐ dependent amyloid precursor protein processing

  2003cited by this paper
• The metallobiology of Alzheimer's disease.

  2003cited by this paper
• Iron misregulation in the brain: a primary cause of neurodegenerative disorders.

  2003cited by this paper
• Genetic or pharmacological iron chelation prevents MPTP-induced neurotoxicity in vivo: a novel therapy for Parkinson's disease.

  2003cited by this paper
• An Iron-responsive Element Type II in the 5′-Untranslated Region of the Alzheimer's Amyloid Precursor Protein Transcript*

  2002cited by this paper
• Mitochondrial permeability transition mediates apoptosis induced by N‐methyl(R)salsolinol, an endogenous neurotoxin, and is inhibited by Bcl‐2 and rasagiline, N‐propargyl‐1(R)‐aminoindan

  2002cited by this paper
• Novel cellular defenses against iron and oxidation: ferritin and autophagocytosis preserve lysosomal stability in airway epithelium

  2001cited by this paper
• Transfection‐enforced Bcl‐2 overexpression and an anti‐Parkinson drug, rasagiline, prevent nuclear accumulation of glyceraldehyde‐3‐phosphate dehydrogenase induced by an endogenous dopaminergic neurotoxin, N‐methyl(R)salsolinol

  2001cited by this paper
• Role of Free Radicals in the Neurodegenerative Diseases

  2001cited by this paper
• Treatment with a copper-zinc chelator markedly and rapidly inhibits beta-amyloid accumulation in Alzheimer's disease transgenic mice.

  2001cited by this paper
• Chemistry and biochemistry of oxidative stress in neurodegenerative disease.

  2001cited by this paper
• Enhancing effect of rasagiline on superoxide dismutase and catalase activities in the dopaminergic system in the rat.

  2000cited by this paper
• In vivo evaluation of brain iron in Alzheimer disease using magnetic resonance imaging.

  2000cited by this paper
• Alterations in the interaction between iron regulatory proteins and their iron responsive element in normal and Alzheimer's diseased brains.

  2000cited by this paper
• Amyloid‐β Deposition in Alzheimer Transgenic Mice Is Associated with Oxidative Stress

  1998cited by this paper
• Green tea constituent epigallocatechin-3-gallate and induction of apoptosis and cell cycle arrest in human carcinoma cells.

  1997cited by this paper
• Cellular injury induced by oxidative stress is mediated through lysosomal damage.

  1995cited by this paper
• H2O2-mediated damage to lysosomal membranes of J-774 cells.

  1993cited by this paper
• Ferritin: a cytoprotective antioxidant strategem of endothelium.

  1992cited by this paper
• Intramuscular desferrioxamine in patients with Alzheimer's disease.

  1991cited by this paper

• Therapeutic potential of synthetic and natural iron chelators against ferroptosis

  2024cites this paper
• The Neuroprotective Activities of the Novel Multi-Target Iron-Chelators in Models of Alzheimer’s Disease, Amyotrophic Lateral Sclerosis and Aging

  2023cites this paper
• Epigallocatechin Gallate Modulates Microglia Phenotype to Suppress Pro-inflammatory Signalling Cues and Inhibit Phagocytosis

  2023cites this paper
• Food‐borne polyphenols: A biocompatible anchor recuperating iron homeostasis

  2023cites this paper
• The Potential Role of Epigallocatechin-3-Gallate (EGCG) in Breast Cancer Treatment

  2023cites this paper
• Liposomal Epigallocatechin-3-Gallate for the Treatment of Intestinal Dysbiosis in Children with Autism Spectrum Disorder: A Comprehensive Review

  2023cites this paper
• Epigallocatechin gallate for Parkinson's disease

  2022cites this paper
• Role of Tea and Its Components in Treatment of Neurodegenerative Diseases: A Review

  2022influential citation
• Dietary Plant Polyphenols as the Potential Drugs in Neurodegenerative Diseases: Current Evidence, Advances, and Opportunities

  2022cites this paper
• Effects of green tea extract treatment on erythropoiesis and iron parameters in iron-overloaded β-thalassemic mice

  2022cites this paper
• Current update on the protective effect of epicatechin in neurodegenerative diseases

  2022cites this paper
• Multifaceted role of polyphenols in the treatment and management of neurodegenerative diseases.

  2022cites this paper
• Neuroprotection and Neurorestoration of Nigra Striatal Dopamine Neurons by Novel Multitarget Drugs, M30

  2021cites this paper
• Role of Iron in the Molecular Pathogenesis of Diseases and Therapeutic Opportunities.

  2021cites this paper
• Effects and Mechanisms of Tea on Parkinson’s Disease, Alzheimer’s Disease and Depression

  2021cites this paper
• The Role and Mechanisms of Action of Catechins in Neurodegenerative Diseases.

  2021cites this paper
• Polyphenols from Thelesperma megapotamicum and Their Antioxidant and Neuroprotective Activities

  2020cites this paper
• Protective Effects of Epigallocatechin Gallate (EGCG) on Endometrial, Breast, and Ovarian Cancers

  2020cites this paper
• Exploring the Multifunctional Neuroprotective Promise of Rasagiline Derivatives for Multi-Dysfunctional Alzheimer's Disease.

  2020cites this paper
• Management of Iron Overload in Resource Poor Nations: A Systematic Review of Phlebotomy and Natural Chelators

  2020cites this paper
• Mitigative effects of epigallocatechin gallate in terms of diminishing apoptosis and oxidative stress generated by the combination of lead and amyloid peptides in human neuronal cells

  2019cites this paper
• The Efficacy of Iron Chelators for Removing Iron from Specific Brain Regions and the Pituitary—Ironing out the Brain

  2019cites this paper
• Studying Huntington’s Disease in Yeast: From Mechanisms to Pharmacological Approaches

  2018cites this paper
• Adult‐onset brain tumors and neurodegeneration: Are polyphenols protective?

  2018cites this paper
• Association of Tea Consumption with Risk of Alzheimer’s Disease and Anti-Beta-Amyloid Effects of Tea

  2018cites this paper
• The green tea polyphenolic catechin epigallocatechin gallate and neuroprotection

  2018cites this paper
• Neuroprotective Effects and Mechanisms of Tea Bioactive Components in Neurodegenerative Diseases

  2018cites this paper
• Nose‐to‐brain drug delivery: An update on clinical challenges and progress towards approval of anti‐Alzheimer drugs

  2018cites this paper
• The mechanism of action of clioquinol for the treatment of Alzheimer's disease

  2018cites this paper
• 7 Free Radicals , Neuronal Death and Neuroprotection

  2017cites this paper
• The protective role of plant biophenols in mechanisms of Alzheimer's disease.

  2017cites this paper
• Chapter 6 – Pleiotropic Theory

  2017cites this paper
• Mechanistic comparison of current pharmacological treatments and novel phytochemicals to target amyloid peptides in Alzheimer’s and neurodegenerative diseases

  2017cites this paper
• Vanillic acid attenuates Aβ1-42-induced oxidative stress and cognitive impairment in mice

  2017cites this paper
• The novel multitarget iron chelating and propargylamine drug M30 affects APP regulation and processing activities in Alzheimer's disease models

  2017influential citation
• Effects of epigallocatechin-3-gallate on proliferation and differentiation of mouse cochlear neural stem cells: Involvement of PI3K/Akt signaling pathway.

  2016cites this paper
• Neuroprotective effects of multifaceted hybrid agents targeting MAO, cholinesterase, iron and β‐amyloid in ageing and Alzheimer's disease

  2016influential citation
• Epigallocatechin-3-gallate rescues LPS-impaired adult hippocampal neurogenesis through suppressing the TLR4-NF-κB signaling pathway in mice

  2015cites this paper
• Epigallocatechin-3-gallate rescues LpS-impaired adult hippocampal neurogenesis through suppressing the TLR4-NF- k B signaling pathway in mice

  2015cites this paper
• The Multi-Target Drug M30 Shows Pro-Cognitive and Anti-Inflammatory Effects in a Rat Model of Alzheimer’s Disease

  2015cites this paper
• New Approaches to Treating Alzheimer’s Disease

  2015cites this paper
• Yeast as a platform for identification of chemo-protectors of Alzheimer's disease

  2015cites this paper
• Galangin-induced down-regulation of BACE1 by epigenetic mechanisms in SH-SY5Y cells.

  2015cites this paper
• Pharmacology of Olive Biophenols in Alzheimer's Disease Prevention and Treatment

  2015cites this paper
• (-)-Epigallocatechin-3-Gallate Modulates Spinal Cord Neuronal Degeneration by Enhancing Growth-Associated Protein 43, B-Cell Lymphoma 2, and Decreasing B-Cell Lymphoma 2-Associated X Protein Expression after Sciatic Nerve Crush Injury

  2015cites this paper
• Potential neuroprotective properties of epigallocatechin-3-gallate (EGCG)

  2015cites this paper
• Perspectives in Medicinal Chemistry.

  2015cites this paper
• Cannabidiol Normalizes Caspase 3, Synaptophysin, and Mitochondrial Fission Protein DNM1L Expression Levels in Rats with Brain Iron Overload: Implications for Neuroprotection

  2014cites this paper
• Biological metals and metal-targeting compounds in major neurodegenerative diseases.

  2014cites this paper
• Puerarin alleviates cognitive impairment and oxidative stress in APP/PS1 transgenic mice.

  2014cites this paper
• Molecular targets of the multifunctional iron‐chelating drug, M30, in the brains of mouse models of type 2 diabetes mellitus

  2014influential citation
• Dietary Lipid Unsaturation Influences Survival and Oxidative Modifications of an Amyotrophic Lateral Sclerosis Model in a Gender-Specific Manner

  2014cites this paper
• Intranasal deferoxamine reverses iron-induced memory deficits and inhibits amyloidogenic APP processing in a transgenic mouse model of Alzheimer's disease.

  2013cites this paper
• Cognitive Enhancers (Nootropics). Part 3: Drugs Interacting with Targets other than Receptors or Enzymes. Disease-modifying Drugs

  2013cites this paper
• Promise of Neurorestoration and Mitochondrial Biogenesis in Parkinson's Disease with Multi Target Drugs: An Alternative to Stem Cell Therapy

  2013cites this paper
• Recent Advances in ALS Research: Perspectives for Personalized Clinical Application

  2013cites this paper
• Polyphenols: Multipotent Therapeutic Agents in Neurodegenerative Diseases

  2013cites this paper
• Targeting dysregulation of brain iron homeostasis in Parkinson's disease by iron chelators.

  2013cites this paper
• Cognitive Enhancers (Nootropics). Part 2: Drugs Interacting with Enzymes

  2013cites this paper
• Dual inhibitors of monoamine oxidase and cholinesterase for the treatment of Alzheimer disease.

  2013cites this paper
• The multifactorial nature of Alzheimer's disease for developing potential therapeutics.

  2013cites this paper
• Patterns of histone acetylation as targets for novel therapeutic approaches in neurological diseases

  2013cites this paper
• A delicate balance: Iron metabolism and diseases of the brain

  2013cites this paper
• Novel chelators targeting cell cycle arrest, acetylcholinesterase, and monoamine oxidase for Alzheimer's therapy.

  2012cites this paper
• The Novel Multi-Target Iron Chelating-Radical Scavenging Compound M30 Possesses Beneficial Effects on Major Hallmarks of Alzheimer's Disease

  2012cites this paper
• Neuroprotection by the multitarget iron chelator M30 on age-related alterations in mice.

  2012cites this paper
• Natural polyphenols against neurodegenerative disorders: potentials and pitfalls.

  2012cites this paper
• Effects of novel neuroprotective and neurorestorative multifunctional drugs on iron chelation and glucose metabolism

  2012cites this paper
• Targeting dysregulation of brain iron homeostasis in ageing

  2012influential citation
• From Anti-Parkinson's Drug Rasagiline to Novel Multitarget Iron Chelators with Acetylcholinesterase and Monoamine Oxidase Inhibitory and Neuroprotective Properties for Alzheimer's Disease

  2012cites this paper
• Chelating agents for neurodegenerative diseases.

  2012cites this paper
• Investigation of the effects of a new synthetic iron nanochelator on neuronal excitability in the presence and absence of oxidative stress

  2012cites this paper
• Green Tea Flavan-3-ols and Their Role in Protecting against Alzheimer’s and Parkinson’s Disease Pathophysiology

  2012cites this paper
• Modulating the Pharmacokinetics of Bioflavonoids

  2012cites this paper
• Polyphenol compounds as antioxidants for disease prevention: Reactive oxygen species scavenging, enzyme regulation, and metal chelation mechanisms in E. coli and human cells

  2011cites this paper
• Iron chelation and neuroprotection in neurodegenerative diseases

  2011cites this paper
• Multi-target-directed ligands in Alzheimer's disease treatment.

  2011cites this paper
• A safe, blood-brain barrier permeable triphenylmethane dye inhibits amyloid-β neurotoxicity by generating nontoxic aggregates.

  2011cites this paper
• Free Radicals, Neuronal Death and Neuroprotection

  2011cites this paper
• Iron-chelating backbone coupled with monoamine oxidase inhibitory moiety as novel pluripotential therapeutic agents for Alzheimer’s disease: a tribute to Moussa Youdim

  2011cites this paper
• Neurological Disorders Associated with Iron Misdistribution: The Therapeutic Potential of Siderophores

  2011cites this paper
• Transcriptional regulation and multiple functions of MAO genes

  2011cites this paper
• Multifunctional neuroprotective derivatives of rasagiline as anti-alzheimer’s disease drugs

  2011cites this paper
• Novel molecular targets of the neuroprotective/neurorescue multimodal iron chelating drug M30 in the mouse brain.

  2011cites this paper
• Limited Potentiation of Blood Pressure in Response to Oral Tyramine by the Anti-Parkinson Brain Selective Multifunctional Monoamine Oxidase-AB Inhibitor, M30

  2010cites this paper
• Anti-inflammatory and anti-oxidant neuroprotection in the prevention of Alzheimer's disease

  2010cites this paper
• Neuroprotective Multifunctional Iron Chelators: From Redox-Sensitive Process to Novel Therapeutic Opportunities

  2010influential citation
• Potential Therapeutic Strategies for Neurodegenerative Diseases

  2010cites this paper
• Propargylamine Containing Compounds as Modulators of Proteolytic Cleavage of Amyloid Protein Precursor: Involvement of MAPK and PKC Activation

  2010influential citation
• Towards a unifying, systems biology understanding of large-scale cellular death and destruction caused by poorly liganded iron: Parkinson’s, Huntington’s, Alzheimer’s, prions, bactericides, chemical toxicology and others as examples

  2010cites this paper
• Monoamine oxidase inhibitors as neuroprotective agents in age-dependent neurodegenerative disorders.

  2010cites this paper
• 14 Alzheimer's Dementia

  2010cites this paper
• Thermodynamic analysis of the molecular interactions between amyloid beta-peptide 42 and (-)-epigallocatechin-3-gallate.

  2010cites this paper
• Oxidative stress and Alzheimer’s disease: dietary polyphenols as potential therapeutic agents

  2010cites this paper
• Site-Activated Chelators Derived from Anti-Parkinson Drug Rasagiline as a Potential Safer and More Effective Approach to the Treatment of Alzheimer’s Disease

  2010cites this paper
• Up-regulation of hypoxia-inducible factor (HIF)-1α and HIF-target genes in cortical neurons by the novel multifunctional iron chelator anti-Alzheimer drug, M30.

  2010cites this paper
• Epigallocatechin gallate inhibits beta amyloid oligomerization in Caenorhabditis elegans and affects the daf-2/insulin-like signaling pathway.

  2010cites this paper
• Synthesis and Characterization of Second- Generation Iron Pro-chelators

  2010cites this paper
• Recent advances in amyotrophic lateral sclerosis research: perspectives for personalized clinical application

  2010cites this paper
• Minding metals: tailoring multifunctional chelating agents for neurodegenerative disease.

  2010cites this paper